SW1990 cells were treated with both the shARHGAP30 lentivirus and the β-catenin inhibitor XAV939, and the mechanism by which ARHGAP30 regulates pancreatic cancer was explored. Here, ARHGAP30 is linked to pancreatic neoplasm.